维持性血液透析患者感染新型冠状病毒后并发免疫性血小板减少一例_West China Medical Journal

Authors：

任文 ¹ , 王燕 ¹ , 沈玉婷 ^1,2 , 付平 ¹ , 李玲 ¹ ,  郑兰 ^1,3

1. ;
2. ;
3. ;

Corresponding author：

郑兰, Email: 1187616487@qq.com

Keywords：

血液透析; 新型冠状病毒; 免疫性血小板减少

DOI：

10.7507/1002-0179.202306133

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 任文, 王燕, 沈玉婷, 付平, 李玲, 郑兰. 维持性血液透析患者感染新型冠状病毒后并发免疫性血小板减少一例. West China Medical Journal, 2024, 39(7): 1168-1170. doi: 10.7507/1002-0179.202306133 Copy

1.	Tumaini Massaro J, Chen Y, Ke Z. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis. Platelets, 2019, 30(7): 828-835.
2.	Kostic M, Zivkovic N, Cvetanovic A, et al. CD4⁺ T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol, 2020, 351: 104096.
3.	Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev, 2021, 20(4): 102792.
4.	Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis, 2019, 26(1): 8-15.
5.	Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol, 2020, 31(7): 1387-1397.
6.	Zou R, Chen F, Chen D, et al. Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center. Ren Fail, 2020, 42(1): 950-957.
7.	Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int, 2020, 98(1): 20-26.
8.	Rahim S, Dhrolia MF, Nasir K, et al. Clinical characteristics and outcomes of coronavirus disease 2019 infection of in-center hemodialysis patients: an experience of a dialysis center from Pakistan. Saudi J Kidney Dis Transpl, 2022, 33(1): 16-30.
9.	Yadla M, Vadakkeveetil AK, Cherian A, et al. Clinical features and outcomes of 84 COVID-positive hemodialysis patients in a resource poor setting from India. Saudi J Kidney Dis Transpl, 2021, 32(2): 504-509.
10.	David P, Dotan A, Mahroum N, et al. Immune thrombocytopenic purpura (ITP) triggered by COVID-19 infection and vaccination. Isr Med Assoc J, 2021, 23(6): 378-380.
11.	Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol, 2017, 177(1): 27-38.
12.	Ochani R, Asad A, Yasmin F, et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med, 2021, 29(1): 20-36.
13.	许莹, 王亚萍, 林莹, 等. 新型冠状病毒感染合并重度免疫性血小板减少症 1 例报告. 内科急危重症杂志, 2021, 27(6): 523-525.

1. Tumaini Massaro J, Chen Y, Ke Z. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenic purpura: meta-analysis. Platelets, 2019, 30(7): 828-835.
2. Kostic M, Zivkovic N, Cvetanovic A, et al. CD4⁺ T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol, 2020, 351: 104096.
3. Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev, 2021, 20(4): 102792.
4. Syed-Ahmed M, Narayanan M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis, 2019, 26(1): 8-15.
5. Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol, 2020, 31(7): 1387-1397.
6. Zou R, Chen F, Chen D, et al. Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center. Ren Fail, 2020, 42(1): 950-957.
7. Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int, 2020, 98(1): 20-26.
8. Rahim S, Dhrolia MF, Nasir K, et al. Clinical characteristics and outcomes of coronavirus disease 2019 infection of in-center hemodialysis patients: an experience of a dialysis center from Pakistan. Saudi J Kidney Dis Transpl, 2022, 33(1): 16-30.
9. Yadla M, Vadakkeveetil AK, Cherian A, et al. Clinical features and outcomes of 84 COVID-positive hemodialysis patients in a resource poor setting from India. Saudi J Kidney Dis Transpl, 2021, 32(2): 504-509.
10. David P, Dotan A, Mahroum N, et al. Immune thrombocytopenic purpura (ITP) triggered by COVID-19 infection and vaccination. Isr Med Assoc J, 2021, 23(6): 378-380.
11. Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients?. Br J Haematol, 2017, 177(1): 27-38.
12. Ochani R, Asad A, Yasmin F, et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med, 2021, 29(1): 20-36.
13. 许莹, 王亚萍, 林莹, 等. 新型冠状病毒感染合并重度免疫性血小板减少症 1 例报告. 内科急危重症杂志, 2021, 27(6): 523-525.

Previous Article
Recent advances in lipid metabolism of acute leukemia
Next Article
产前超声表现为胎儿多囊性肾发育不良的Williams-Beuren 综合征两例

West China Medical Journal

维持性血液透析患者感染新型冠状病毒后并发免疫性血小板减少一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content